CY1114525T1 - (S) -N-METHYLNALTREXONE, (METHYLNALTREXONE), PROCEDURES FOR COMPOSITION AND PHARMACEUTICAL USE - Google Patents

(S) -N-METHYLNALTREXONE, (METHYLNALTREXONE), PROCEDURES FOR COMPOSITION AND PHARMACEUTICAL USE

Info

Publication number
CY1114525T1
CY1114525T1 CY20131100935T CY131100935T CY1114525T1 CY 1114525 T1 CY1114525 T1 CY 1114525T1 CY 20131100935 T CY20131100935 T CY 20131100935T CY 131100935 T CY131100935 T CY 131100935T CY 1114525 T1 CY1114525 T1 CY 1114525T1
Authority
CY
Cyprus
Prior art keywords
methylnaltrexone
procedures
composition
pharmaceutical use
mntx
Prior art date
Application number
CY20131100935T
Other languages
Greek (el)
Inventor
Howard Wagoner
Suketu P Sanghvi
Thomas A Boyd
Christopher Verbicky
Stephen Andruski
Original Assignee
Progenics Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06771162.2A external-priority patent/EP1928882B1/en
Application filed by Progenics Pharmaceuticals, Inc. filed Critical Progenics Pharmaceuticals, Inc.
Publication of CY1114525T1 publication Critical patent/CY1114525T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Αυτή η εφεύρεση σχετίζεται με την S-MNTX, με μεθόδους παραγωγής της S-MNTX, με φαρμακευτικά παρασκευάσματα που περιλαμβάνουν την S-MNTX και μεθόδους για την χρήση τους.This invention relates to S-MNTX, to methods of producing S-MNTX, to pharmaceutical preparations comprising S-MNTX, and to methods for their use.

CY20131100935T 2005-05-25 2013-10-23 (S) -N-METHYLNALTREXONE, (METHYLNALTREXONE), PROCEDURES FOR COMPOSITION AND PHARMACEUTICAL USE CY1114525T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68457005A 2005-05-25 2005-05-25
EP06771162.2A EP1928882B1 (en) 2005-05-25 2006-05-25 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use

Publications (1)

Publication Number Publication Date
CY1114525T1 true CY1114525T1 (en) 2016-10-05

Family

ID=58448767

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100935T CY1114525T1 (en) 2005-05-25 2013-10-23 (S) -N-METHYLNALTREXONE, (METHYLNALTREXONE), PROCEDURES FOR COMPOSITION AND PHARMACEUTICAL USE

Country Status (1)

Country Link
CY (1) CY1114525T1 (en)

Similar Documents

Publication Publication Date Title
CY1118454T1 (en) ORIGINAL PYROLLI INHIBITORS OF S-NITROZOGLUTATHYONE PRODUCTION AS THERAPEUTIC AGENTS
TW200716646A (en) (S)-N-methylnaltrexone
CY1120994T1 (en) INNOVATIVE SOLUTION COMPOSITIONS CONTAINING CELLULAR AGENTS AND USING THEM FOR WOUND TREATMENT
CY1120670T1 (en) MONOCLONIC ANTIBODIES AGAINST TISSUE FACTOR INHIBITOR (TFPI)
CY1116264T1 (en) ANTIBODIES AGAINST HUMAN VASCULAR 2
CY1118038T1 (en) FOLLOWED PHARMACEUTICAL FORMS OF THERAPEUTIC DISPOSAL
NO20170633A1 (en) Compounds of indolamine-2,3-dioxygenase for use in the treatment of cancer in combination with an anti-PD-1 antibody.
CY1118661T1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCEDURE FOR THEIR PREPARATION, METHODS FOR TREATMENT AND USE OF THESE
CY1112781T1 (en) 2'-FLUORO-2'-DEOXYTETRAHYROIDURIDES AS CYTIDINE DISEASE INHIBITORS
CY1115082T1 (en) Substituted 1,3-bisphenylpropane derivatives, preparations and their uses
MA32161B1 (en) Rifaximin forms and uses thereof
CY1109010T1 (en) c-crystalline form of hydrochloride ivabradine, its preparation method and the pharmaceutical compositions containing it
CY1112682T1 (en) Active IL-18 Protein Conjugates and their Medical Uses
EA201170227A1 (en) ИМИДАЗОЛКАРБОКСАМИДЫ
CY1110926T1 (en) Substituted Rocket Pyridines, Compositions Containing them, Preparation Procedure and Use
NO20083895L (en) Anti-IGF-1R human monoclonal antibody formulation
TW200716647A (en) Synthesis of (R)-N-methylnaltrexone
ECSP10010548A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
ATE489371T1 (en) BENZAMIDE GLUCOCINASE ACTIVATORS
CY1117288T1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivative
CY1113551T1 (en) Substituted nicotinamide compounds and their use in medicinal products
SV2005002015A (en) PROCESSES FOR THE PREPARATION OF HALUROS DE ARIL- Y HETEROARIL-ALQUILSULFONILO - REF. WYTH0008-504 (AM101302)
BRPI0408848B8 (en) pharmaceutical compositions of complex cyclodextrin-cladribine complex, uses of said complex, as well as processes for its preparation
NO20076120L (en) Stable nanoparticle formulations
SE0300457D0 (en) Novel compounds